Angiopoietin 2 expression in invasive ductal carcinoma of the breast: Its relationship to the VEGF expression and microvessel density

Breast Cancer Research and Treatment

Volumn 98, Issue 3, 2006, Pages 261-266

  Tsutsui, Shinichi ^a   Inoue, Hiroshi ^b   Yasuda, Kazuhiro ^c   Suzuki, Kosuke ^c   Takeuchi, Hideya ^c   Nishizaki, Takashi ^a   Higashi, Hidefumi ^c   Era, Shoichi ^c   Mori, Masaki ^b  

^a MATSUYAMA RED CROSS HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION BEPPU MEDICAL CENTER   (Japan)

Author keywords

Angiogenesis; Angiopoietin; Breast cancer; Microvessel density; VEGF

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN 2; LIGAND; TYROSINE KINASE RECEPTOR; TYROSINE KINASE RECEPTOR TIE 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BREAST CANCER; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROVASCULATURE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPOIETIN-2; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33746932442     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9157-9     Document Type: Article

References (29)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31, 1995
2. Weider N, Semple SP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991
3. Tsutsui S, Kume M, Era S: Prognostic value of microvessel density in invasive ductal carcinoma of the breast. Breast Cancer 10: 312-319, 2003
4. Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S: Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14: 425-431, 2005
5. Ferrara N, Gerber H, LeCouter J: The biology of VEGF and its receptors. Nature Med 9: 669-676, 2003
6. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopuolos N, Daly TJ, Davis S, Sato TN, Yacopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60, 1997
7. Holash J, Wiegand SJ, Yancopoulos GD: New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18: 5356-5362, 1999
8. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J: Vascular-specific growth factors and blood vessel formation. Nature 407: 242-248, 2000
9. Tait CR, Jones PF: Angiopoietins in tumours; the angiogenic switch. J Pathol 204: 1-10, 2004
10. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, Wieganad SJ: Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284: 1994-1998, 1999
11. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y: Hypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 274: 15732-15739, 1999
12. Lobov IB, Brooks PC, Lang RA: Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 99: 11205-11210, 2002
13. Visconti RP, Richardson CD, Sato TN: Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc Natl Acad Sci USA 99: 8219-8224, 2002
14. Osada H, Tokunaga T, Hatanaka H, Kawakami T, Tsuchida T, Abe Y, Tsugu A, Kijima H, Yamazaki H, Shima K, Osamura Y, Ueyama Y, Nakamura M: Gene expression of angiogenesis related factors in glioma. Int J Oncol 18: 305-309, 2001
15. Moon WS, Rhyu KH, Kang MJ, Lee DG, Yu HC, Yeum JH, Koh GY, Tarnawski AS: Overexpression of VEGF and angiopoietin 2: A key to high vascularity of hepatocellular carcinoma? Mod Pathol 16: 552-557, 2003
16. Sun X, Liu X, Wu J, Cai X, Mou Y, Li J: Expression and significance of angiopoietin-2 in gastric cancer. World J Gastroenterol 10: 1382-1385, 2004
17. Zhang L, Yang N, Park J, Katsaros D, Fracchioli S, Cao G, O'brien-Jenkins A, Randall TC, Rubin SC, Coukos G: Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 63: 3403-3412, 2003
18. Currie MJ, Gunningham SP, Han C, Scott PAE, Robinson BA, Harris AL, Fox SB: Angiopoietin-1 is inversely related to thymidine phophorylase expression in human breast cancer, indicating a role in vascular remodeling. Clin Cancer Res 7: 918-927, 2001
19. Sfiligoi C, De Luca A, Cascone I, Sorbello V, Fuso L, Ponzone R, Biglia N, Audero E, Arisio R, Bussolino F, Sismondi P, De Bortoli M: Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer 103: 466-474, 2003
20. Mituhashi N, Shimizu H, Ohtsuka M, Wakabayashi Y, Ito H, Kimura F, Yoshidome Y, Kato A, Nukui Y, Miyazaki M: Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocelluar carcinoma. Hepatol 37: 1105-1113, 2003
21. Tanaka F, Ishikawa S, Yanagihara K, Miyahara R, Kawano Y, Li M, Otake Y, Wada H: Expression of angiopoietins and its clinical significance in non-small cell lung cancer. Cancer Res 62: 7124-7129, 2002
22. Takanami I: Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis. Oncol Rep 12: 849-853, 2004
23. Ochiumi T, Tanaka S, Oka S, Hiyama T, Ito M, Kitadai Y, Haruma K, Chayama K.: Clinical significance of angiopoietin-2 expression at the deepest invasive tumor site of advanced colorectal carcinoma. Int J Onocol 24: 539-547, 2004
24. Hata K, Nakayama K, Fujiwaki R, Katabuchi H, Okamura H, Miyazaki K: Expression of the angiopoietin-1, angiopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer. Gynecol Oncol 93: 215-222, 2004
25. Lind AJ, Wikstrom P, Granfors T, Egevad L, Stattin P, Bergh A: Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer. Prostate 62: 394-399, 2005
26. Tsutsui S, Yasuda K, Higashi H, Tahara K, Sugita S, Eguchi H, Kayashima H, Miyazaki N, Muto Y, Era S: Prognostic implication of p53 protein expression in relation to nuclear pleomorphism and the MIB-1 counts in breast cancer. Breast Cancer 11: 160-168, 2004
27. Volm M, Koomagi R, Mattern J: Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer 74: 64-68, 1997
28. Etoh T, Inoue H, Tanaka S, Barnard GF, Kitano S, Mori M: Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: Possible in vivo regulation via induction of proteases. Cancer Res 61: 2145-2153, 2001
29. Oka N, Yamamoto Y, Takahashi M, Nishitani M, Kanayama H, Kagawa S: Expression of angiopoietin-1 and -2, and its clinical significance in human bladder cancer. BJU Int 95: 660-663, 2005